13 February 2026 How to assess for disease remodelling using imaging techniques Presented at PVRI 2026 Congress by Farbod N. Rahaghi, UCLA Health PVRI 2026 Dublin
13 February 2026 Assessing PAH disease remission in a clinical trial Presented at PVRI 2026 Congress by Jim White, University of Rochester PVRI 2026 Dublin
13 February 2026 If you had it all: designing the ideal paediatric PH clinical trial Presented at PVRI 2026 Congress by Megan Griffiths, University of Texas Southwestern PVRI 2026 Dublin
13 February 2026 KEYNOTE: REMAP ILD - Lessons to REMAP PAH Presented at PVRI 2026 Congress by Gisli Jenkins, Imperial College London PVRI 2026 Dublin
13 February 2026 IDDI Workstream Satellite meeting: Panel discussion Presented at PVRI 2026 Congress by Namita Sood, University of California & Luke Howard, Imperial College London PVRI 2026 Dublin
13 February 2026 All should be eligible? The great PAH trial debate Presented at PVRI 2026 Congress by Sandeep Sahay, Houston Methodist Hospital, and Meredith Broderick, United Therapeutics PVRI 2026 Dublin
13 February 2026 The fourth pillar of PH care: Activation & community-linkage as therapeutic interventions? Presented at PVRI 2026 Congress by Franz Rischard, University of Arizona PVRI 2026 Dublin
13 February 2026 Data elements collected within PH registries: A scoping review Presented at PVRI 2026 Congress by Kari Gillmeyer, Boston University & Sarah Cohen, The Ohio State University & Nationwide Children's Hospital PVRI 2026 Dublin
13 February 2026 Therapies in the real world - how much do we diverge from trial populations? Presented at PVRI 2026 Congress by Mark Toshner, University of Cambridge PVRI 2026 Dublin
